Sarah Cannon Research Institute

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Sarah Cannon Research Institute
Jan 21, 2025, 15:31 | Blog
Vivek Subbiah: Delighted to work with an amazing crew at Sarah Cannon Research Institute
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on…
Jan 16, 2025, 10:07 | Oncolibrary,Oncologist Near Me
Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology
Oncologist Near Me: Vivek Subbiah Welcome to OncoDaily’s special section “Oncologist Near Me”, where we introduce prominent oncologists…
Jan 14, 2025, 02:16 | Blog
Navneet Majhail: Great opportunity at Sarah Cannon Transplant and Cellular Therapy Network
Navneet Majhail, Physician-in-Chief of Blood Cancers at the Sarah Cannon Transplant and Cellular Therapy Network,…
Jan 12, 2025, 15:23 | Insight
Krish Patel: Multi-center effort of CD19 allo iPSC CAR-NK in B-cell lymphomas
Krish Patel, Director of the Lymphoma Research Program at the Sarah Cannon Research Institute, shared…
Jan 11, 2025, 16:11 | Blog
Ishwaria Subbiah: Your most enduring professional legacy is not your CV
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research…
Jan 11, 2025, 15:03 | Blog
Noelle (Noelle Gillette) Cloven: New Year, New Progress, Advancing Cervical Cancer Care in 2025
Noelle (Noelle Gillette) Cloven, Executive Chair Gynecologic Cancer Committee at Sarah Cannon Research Institute, shared…
Jan 7, 2025, 17:27 | Blog
3 Key Insights for Patients Considering Clinical Trials from Vivek Subbiah - SCRI
Sarah Cannon Research Institute shared a post on LinkedIn: "Clinical trials are carefully planned tests…
Jan 7, 2025, 11:39 | Blog
Sarah Cannon Research Institute Grows Network with Addition of Mary Crowley Cancer Research
Sarah Cannon Research Institute shared on LinkedIn: "We are excited to announce a significant expansion…
Jan 7, 2025, 10:29 | Blog
Vivek Subbiah: Proud to welcome Mary Crowley Cancer Research to SCRI
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Dec 28, 2024, 16:23 | Blog
Sarah Cannon Transplant and Cellular Therapy Network is hiring
Navneet Majhail, Physician-in-Chief of Blood Cancers at the Sarah Cannon Transplant and Cellular Therapy Network,…
Dec 20, 2024, 02:13 | Blog
Erika Hamilton: Honored to have been elected to the ASCO Nominating Committee
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 18, 2024, 13:19 | Blog
Celebrating 1 Year of SCRI Oncology Partners
SCRI Oncology Partners shared a post on LinkedIn: “Celebrating 1 Year of SCRI Oncology Partners.…
Dec 15, 2024, 18:36 | Blog
More than 65 abstracts and presentations at the 66th ASH Annual Meeting and Exposition by SCRI
Sarah Cannon Research Institute posted on LinkedIn: "And that’s a wrap for ASH24! A standing…
Dec 15, 2024, 08:06 | Blog
Erika Hamilton: Advancing breast cancer care at SABCS
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 14, 2024, 13:35 | Blog
Arif Kamal: Only 7% of adults with a cancer diagnosis enroll in a therapeutic clinical trial
Arif Kamal, Chief Patient Officer for the American Cancer Society, shared a post on LinkedIn:…
Dec 14, 2024, 01:08 | Blog
Erika Hamilton: Does remote symptom monitoring improve fatigue in MBC?
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 13, 2024, 05:58 | Blog
Erika Hamilton: Risk reducing surgery in young BRCA carriers with a prior Breast Cancer, by Matteo Lambertini
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 12, 2024, 16:27 | Insight
Vivek Subbiah: Optimizing Tomorrow’s Drug Development with Project Optimus
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Dec 10, 2024, 18:02 | Blog
Welcoming experts at ASH24 - Sarah Cannon Research Institute
Sarah Cannon Research Institute posted the following on LinkedIn: “After a great first day of…
Dec 9, 2024, 16:49 | Insight
Erika Hamilton: ADCs are changing breast cancer care
Erika Hamilton, Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on LinkedIn:…
Dec 8, 2024, 10:37 | Blog
"Meet the Expert" sessions at the 2024 ASH Annual Meeting - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Exciting News for ASH24 Attendees! The…
Dec 5, 2024, 07:37 | Blog
Vivek Subbiah: AI for early cancer detection in Lancet Oncology
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), posted…
Dec 4, 2024, 22:59 | Blog
Vivek Subbiah: Improving observational studies with target trial emulation
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), posted…
Nov 30, 2024, 19:13 | Insight
Vivek Subbiah: ADC Target Expression and Interstitial Lung Disease in NSCLC
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Nov 30, 2024, 15:12 | Insight
Dee Anna Smith: Celebrating Patient - Centered Care with SCRI Physicians
Dee Anna Smith, Chief Executive Officer at Sarah Cannon Research Institute, posted on LinkedIn: “At…
Nov 29, 2024, 11:11 | Blog
Vivek Subbiah: The state of AI in Precision Oncology
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Nov 28, 2024, 12:35 | Blog
David R. Spigel: Putting the Pieces Together - Looking at Lung Cancer
David R. Spigel, Chief Scientific Officer at Sarah Cannon Research Institute, shared a post on…
Nov 27, 2024, 13:50 | Insight
Development and phenotype of regulatory T cells
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 26, 2024, 23:03 | Blog
Ishwaria Subbiah: Let's Honor the Dedication of Unsung Heroes During National Family Caregivers Month
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research…
Nov 24, 2024, 02:48 | Blog
Vivek Subbiah: Honored to be named one of the 2024 Clarivate Highly Cited Researchers
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on…
Nov 22, 2024, 16:40 | Blog
Voting in the ASCO Election is open until December 3
Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute,…
Nov 21, 2024, 16:49 | Blog
Vivek Subbiah: Incredible Panel Discussion at the Target Cancer Foundation Think Tank
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 21, 2024, 16:00 | Blog
Mark E. Cooper will be joining SCRI to help coordinate a comprehensive breast program
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Nov 21, 2024, 09:18 | Positive
Vivek Subbiah: Delighted to welcome Krish Patel as our new lymphoma leader SCRI
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 20, 2024, 19:12 | Blog
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Dr. Robert Jotte, Disease Chair, Lung Cancer…
Nov 18, 2024, 20:51 | Insight
Vivek Subbiah: Redefining pancreatic cancer management with tumor-agnostic precision medicine
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared his…
Nov 15, 2024, 16:13 | Blog
Vivek Subbiah: An enlightening panel discussion on the latest advancements in oncology at SCRI meeting
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 14, 2024, 14:09 | Blog
Vivek Subbiah: Supporting Dr. Petros Grivas for the Nominating Committee in the ASCO Election for 2025
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 13, 2024, 14:55 | Blog
Krish Patel has been appointed as the New Director of Lymphoma Research at SCRI
Sarah Cannon Research Institute (SCRI), a global leader in oncology research and community-based clinical trials,…
Nov 12, 2024, 01:16 | Insight
The role of PDOs as preclinical models in gene editing for guiding personalized treatment
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared an…
Nov 10, 2024, 15:34 | Blog
Erika Hamilton: ASCO25 abstracts are open!
Erika Hamilton, the Director of Breast Cancer Program at Sarah Cannon Research Institute, shared a…
Oct 29, 2024, 17:50 | Blog
Denis Horgan: Taking our cancer campaign to the White House
Denis Horgan, Executive Director from the European Alliance of Personalised Medicine (EAPM), shared on LinkedIn: "Taking…
Oct 26, 2024, 17:15 | Blog
Vivek Subbiah: Welcoming Deepak Bhamidipati to Sarah Cannon Research Institute Early Phase Drug Development Unit
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Oct 26, 2024, 10:40 | Blog
Erika Hamilton: The latest advances and controversial topics in the field of breast and gynecological cancers
Erika Hamilton, Medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Oct 23, 2024, 13:33 | Blog
Erika Hamilton: Clinical trials should be the first option in fighting cancer not the last
Erika Hamilton shared a post by Sarah Cannon Research Institute on LinkedIn, adding: ''At Sarah…
Oct 22, 2024, 23:50 | Blog
Why clinical trials are essential to delivering patient-centered care - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "October is Patient-Centered Care Awareness Month.…
Oct 22, 2024, 23:24 | Blog
Deepak Bhamidipati appointed as Assistant Director of Drug Development at SCRI
SCRI (Sarah Cannon Research Institute) shared a post on LinkedIn: ''We are thrilled to welcome…
Oct 20, 2024, 13:40 | Insight
The world’s first patient with sickle cell disease to reach the summit of Kilimanjaro
Sarah Cannon Research Institute shared a post on LinkedIn: “Remember Jimi, one of our amazing…
Oct 18, 2024, 15:35 | Blog
Sarah Cannon Research Institute Partners with BostonGene to integrate molecular testing and informatics platforms
Sarah Cannon Research Institute shared a post by BostonGene on LinkedIn, adding: "We are excited to…
Oct 12, 2024, 12:57 | Blog
Jenna Fischer's recent breast cancer battle inspires a conversation around early detection and stage 1 triple positive breast cancer treatment - SCRI
SCRI (Sarah Cannon Research Institute) shared a post on LinkedIn: "Important Update: We hope you had…
Oct 11, 2024, 12:32 | Blog
Erika Hamilton: Reflecting on breast cancer research and the importance of clinical trials
Erika Hamilton posted the following on LinkedIn: “Many of us can recall a time in…
Oct 10, 2024, 15:23 | Blog
Erika Hamilton: The Importance of Mammograms - Early Detection Saves Lives
Erika Hamilton shared a post on LinkedIn: "Many of us can recall a time in our…
Oct 8, 2024, 17:05 | Blog
Vivek Subbiah: Big day for foundational models leading to today's AI
Vivek Subbiah shared about Nobel Prize winners. Read his post on LinkedIn below. "Breaking news.…
Oct 7, 2024, 11:25 | Blog
Jeff Sharman: Reflecting on the incredible progress made in lymphoma research
Jeff Sharman, Medical Director for Hematology Research at US Oncology, shared a post on LinkedIn,…
Oct 6, 2024, 13:26 | Insight
Vivek Subbiah: Fragmentation in medicine harms patients and hinders research
Vivek Subbiah shared a post on LinkedIn about a recent paper "Fragmentation in medicine harms…
Sep 27, 2024, 16:48 | Blog
Skip Burris: Clinical trials should be the first step in fighting cancer
Sarah Cannon Research Institute shared the following on LinkedIn: “Participation in clinical trials should be…
Sep 26, 2024, 06:57 | Blog
Reflecting on advancing cancer treatment through research and innovation - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following on LinkedIn: “Today, on World Cancer Research Day,…
Sep 25, 2024, 12:13 | Insight
World Cancer Research Day 2024: Innovation, Hope, and Progress in the Fight Against Cancer
This year World Cancer Research Day's theme is 'Innovation in Cancer Research Drives Progress Toward…
Sep 17, 2024, 18:36 | Blog
Erika Hamilton: Masterful discussion of ILD with TDXd by Pat LoRusso
Erika Hamilton shared a post on X: "Masterful discussion of ILD with TDXd by Dr.…
Sep 10, 2024, 13:42 | Blog
Vivek Subbiah: A morning walk to support melanoma research
Vivek Subbiah posted on X by himself adding: "Amazing day for a morning walk to…
Sep 9, 2024, 15:30 | Societies
25 Posts Not To Miss from Day 2 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization committed…
Sep 9, 2024, 13:41 | Dialogues
Dr. Vivek Subbiah on Pioneering Precision Oncology and Global Clinical Trials | OncoInfluencers #13
Dr. Vivek Subbiah, Chief of Early Phase Drug Development at Sarah Cannon Research Institute, joins…
Sep 1, 2024, 17:03 | Blog
Vivek Subbiah: Our WHY is YOU!
Vivek Subbiah shared a post on LinkedIn: ''Clinical trials, Drug development unit dream team. Yes!…
Sep 1, 2024, 16:26 | Blog
Vivek Subbiah: Clinical trial vs fiction
Vivek Subbiah shared an article on LinkedIn: ''Every single drug, medicine, and treatment you’ve ever…
Aug 31, 2024, 09:08 | Insight
Vivek Subbiah: Our commentary on Precision oncology across the ages
Vivek Subbiah shared on LinkedIn about a recent paper titled "Precision oncology across the ages:…
Aug 29, 2024, 15:47 | Insight
Navneet Majhail: Advances and practical application of precision medicine in oncology
Navneet Majhail shared a post on LinkedIn: "On Sarah Cannon Cancer Network grand rounds today,…
Aug 26, 2024, 10:00 | Insight
Vivek Subbiah: We need to challenge Standard-of-care Paradigms in the Precision Oncology era
Vivek Subbiah shared a post on LinkedIn: "Such a delight to deliver a lecture and join…
Aug 25, 2024, 13:09 | Blog
Allison Zibelli and Erika Hamilton discussing data from the DESTINY-Breast06 and A-BRAVE trials
Sidney Kimmel Comprehensive Cancer Center at Jefferson shared a post on LinkedIn: "Dr. Allison Zibelli,…
Aug 16, 2024, 14:58 | Blog
Ishwaria Subbiah about fighting burnout on Healthcare Unfiltered with Chadi Nabhan
Chadi Nabhan, Chief Medical Officer and Head of Strategy of Ryght, shared on X: "Can…
Aug 15, 2024, 14:41 | Insight
Vivek Subbiah: Transforming the fragmented silos of medicine into a wheel of collaboration
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post by…
Aug 15, 2024, 13:34 | Blog
Navneet Majhail: New complex blood cancer, HCT, and cellular therapy program at HCA Florida Healthcare North Florida
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon Research Institute, shared a post on…
Aug 14, 2024, 07:07 | Insight
Vivek Subbiah: The evolving landscape of tissue-agnostic therapies in precision oncology
Vivek Subbiah shared on X: "Such a delight to share with in Open Access for…
Aug 14, 2024, 06:17 | Insight
Sumanta K. Pal: Viable solutions to "fragmentation" in medicine
Sumanta K. Pal shared a post by Vivek Subbiah on X: "Wonderful piece in Nature…
Aug 10, 2024, 13:38 | Insight
Vivek Subbiah: Fragmentation in medicine harms patients and hinders research
Vivek Subbiah shared on LinkedIn: "Just published in Nature Medicine: Fragmentation in medicine harms patients…
Aug 6, 2024, 16:22 | Blog
Student Early Exposure - program for students about the possibilities within the field of clinical research, writes Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Attention Students Looking for Professional Development…
Aug 5, 2024, 16:40 | Insight
Shaalan Beg: Modernizing evidence generation for regulatory approvals at ASCOBT24
Shaalan Beg, Senior Advisor for Clinical Research at the National Cancer Institute, shared a post…
Aug 4, 2024, 11:27 | Blog
Vivek Subbiah: You're all going for gold
Vivek Subbiah shared a post on LinkedIn: "Thrilled to see all our staff in the…
Aug 3, 2024, 11:42 | Blog
Ishwaria Subbiah: Privileged to present at the July 1 Rounds of the FDA Oncology Center of Excellence
Ishwaria Subbiah shared a post on LinkedIn: "That's a wrap! July 2024 took me to…
Aug 1, 2024, 15:05 | Blog
Learn about opportunities to join - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Our team members are deeply committed to…
Jul 27, 2024, 22:17 | Insight
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Erika Hamilton shared on X: "This commentary led by Marleen Kok highlights all the pertinent…
Jul 19, 2024, 22:55 | Blog
Potential of "smart warheads" in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Exciting developments in cancer treatment! Erika…
Jul 19, 2024, 08:35 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Erika Hamilton
As our next oncoinfluencer we are excited to feature Dr. Erika Hamilton, a prominent medical…
Jul 13, 2024, 12:13 | Insight
Vivek Subbiah: Great JAMA weekend read on highlights from ASCO24
Vivek Subbiah shared on LinkedIn: "Happy Friday, World! Hot off the press - published in…
Jul 12, 2024, 19:08 | Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Jul 12, 2024, 11:08 | Blog
Vivek Subbiah: How to Spend Way Less Time on Email Every Day
Vivek Subbiah shared a post on X: "How to Spend Way Less Time on Email…
Jul 5, 2024, 02:47 | Drugs
A new standard for treating limited-stage small cell lung cancer - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Dr. David R. Spigel recently shared research on durvalumab…
Jul 2, 2024, 05:00 | Insight
AlphaFold’s recent advancements and its potential impact on predictive medicine
AI in Precision Oncology  shared a post on X: "AIPO is excited to publish a…
Jul 1, 2024, 16:19 | Insight
Vivek Subbiah: Two back to back futuristic papers in the journal AI In Precision Oncology
Vivek Subbiah shared on LinkedIn: “Thrilled to have the opportunity to mentor some of the…
Jul 1, 2024, 15:15 | Blog
Cesar Perez: Increasing the Impact of Immunotherapy
Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…
Jul 1, 2024, 14:03 | Drugs
Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Significant advancements in NSCLC treatment! SCRI's Dr. Robert Jotte…
Jul 1, 2024, 02:25 | Blog
Insights from ESMOGI24 by Cathy Eng
ESMO GI 2024 took place from June 26 to 29 in Munich, Germany, featuring both…
Jun 29, 2024, 10:28 | Blog
David R. Spigel's presentation at the 2024 ASCO on crucial developments in lung cancer treatment - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: “David R. Spigel, presentation at the…
Jun 29, 2024, 09:05 | Blog
Erika Hamilton: Always worth major celebration when we see survival improve by 10 months in metastatic cancer
Erika Hamilton shared a post by Healthbook on LinkedIn, adding: "Always worth major celebration when we…
Jun 28, 2024, 06:15 | Blog
The American Journal of Managed Care highlights the latest research from Erika Hamilton
Sarah Cannon Research Institute shared the following post on LinkedIn: “AJMC - The American Journal…
Jun 26, 2024, 02:20 | Insight
Brigatinib in NF2-Related Schwannomatosis
Vivek Subbiah shared on X: “Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors. NF2-related schwannomatosis (NF2-SWN,…
Jun 25, 2024, 04:14 | Blog
Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma at ecancer - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma…
Jun 24, 2024, 17:19 | Blog
David R. Spigel commented on the major lung cancer research updates for Patient Power
Sarah Cannon Research Institute shared on LinkedIn:                 .…
Jun 24, 2024, 15:19 | Insight
Vivek Subbiah: Precision therapy with ALK inhibitor in ALCL
Vivek Subbiah shared on X:          .  "Precision therapy with anaplastic lymphoma…
Jun 24, 2024, 13:33 | Blog
Erika Hamilton's insights into the future of ADCs in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following post on LinkedIn: “We are thrilled to share…
Jun 22, 2024, 15:13 | Drugs
Vivek Subbiah: Another FDA approval to adagrasib plus cetuximab for KRAS G12C-mutated colorectal cancer
Vivek Subbiah shared on LinkedIn: "It's Friday and time for another FDA approval! FDA grants…
All: 223 Posts: 1 - 100
Special Coverage